2,192 reports of this reaction
1.9% of all LEVETIRACETAM IN SODIUM CHLORIDE reports
#9 most reported adverse reaction
CONDITION AGGRAVATED is the #9 most commonly reported adverse reaction for LEVETIRACETAM IN SODIUM CHLORIDE, manufactured by Actavis Pharma, Inc.. There are 2,192 FDA adverse event reports linking LEVETIRACETAM IN SODIUM CHLORIDE to CONDITION AGGRAVATED. This represents approximately 1.9% of all 117,343 adverse event reports for this drug.
Patients taking LEVETIRACETAM IN SODIUM CHLORIDE who experience condition aggravated should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CONDITION AGGRAVATED is a less commonly reported adverse event for LEVETIRACETAM IN SODIUM CHLORIDE, but still significant enough to appear in the safety profile.
In addition to condition aggravated, the following adverse reactions have been reported for LEVETIRACETAM IN SODIUM CHLORIDE:
The following drugs have also been linked to condition aggravated in FDA adverse event reports:
CONDITION AGGRAVATED has been reported as an adverse event in 2,192 FDA reports for LEVETIRACETAM IN SODIUM CHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
CONDITION AGGRAVATED accounts for approximately 1.9% of all adverse event reports for LEVETIRACETAM IN SODIUM CHLORIDE, making it a notable side effect.
If you experience condition aggravated while taking LEVETIRACETAM IN SODIUM CHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.